1.26
price down icon1.56%   -0.02
 
loading
Geron Corp stock is traded at $1.26, with a volume of 6.75M. It is down -1.56% in the last 24 hours and down -17.11% over the past month. Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
See More
Previous Close:
$1.28
Open:
$1.3
24h Volume:
6.75M
Relative Volume:
0.66
Market Cap:
$802.52M
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-3.9375
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
+1.61%
1M Performance:
-17.11%
6M Performance:
-58.14%
1Y Performance:
-70.63%
1-Day Range:
Value
$1.25
$1.30
1-Week Range:
Value
$1.20
$1.37
52-Week Range:
Value
$1.17
$4.89

Geron Corp Stock (GERN) Company Profile

Name
Name
Geron Corp
Name
Phone
(650) 473-7700
Name
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
Employee
229
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
GERN's Discussions on Twitter

Compare GERN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GERN
Geron Corp
1.26 815.25M 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Geron Corp Stock (GERN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-10-25 Resumed Goldman Sell
May-08-25 Downgrade Scotiabank Sector Outperform → Sector Perform
Feb-27-25 Downgrade B. Riley Securities Buy → Neutral
Feb-26-25 Downgrade H.C. Wainwright Buy → Neutral
Nov-05-24 Initiated H.C. Wainwright Buy
Oct-16-24 Initiated Scotiabank Sector Outperform
Sep-09-24 Initiated Leerink Partners Outperform
Apr-30-24 Downgrade Robert W. Baird Outperform → Neutral
Apr-29-24 Initiated TD Cowen Buy
Mar-15-24 Reiterated Needham Buy
Sep-12-23 Upgrade Goldman Neutral → Buy
Mar-28-23 Initiated Goldman Neutral
Oct-28-22 Initiated Wedbush Outperform
Jul-28-22 Resumed B. Riley Securities Buy
Nov-02-21 Initiated Robert W. Baird Outperform
Feb-18-21 Resumed B. Riley Securities Buy
Aug-03-20 Initiated Stifel Buy
Nov-19-19 Resumed B. Riley FBR Buy
Sep-03-19 Initiated H.C. Wainwright Buy
Aug-15-19 Initiated Cantor Fitzgerald Overweight
Apr-09-19 Upgrade Needham Hold → Buy
Jan-31-19 Upgrade B. Riley FBR Neutral → Buy
Oct-02-18 Downgrade B. Riley FBR Buy → Neutral
Jul-05-18 Initiated B. Riley FBR, Inc. Buy
Sep-13-16 Reiterated FBR & Co. Outperform
Sep-13-16 Reiterated FBR Capital Outperform
Dec-07-15 Reiterated Piper Jaffray Overweight
Apr-21-15 Initiated Oppenheimer Outperform
Jun-12-14 Upgrade MLV & Co Hold → Buy
Mar-12-14 Downgrade MLV & Co Buy → Hold
Dec-10-13 Reiterated MLV & Co Buy
Dec-10-13 Upgrade Needham Hold → Buy
Nov-08-13 Reiterated MLV & Co Buy
Oct-16-13 Initiated MLV & Co Buy
Aug-30-12 Initiated Stifel Nicolaus Buy
Jun-28-12 Initiated Needham Hold
View All

Geron Corp Stock (GERN) Latest News

pulisher
Jul 26, 2025

How high can Geron Corporation stock price go in 2025Market Timing Advice - Metal.it

Jul 26, 2025
pulisher
Jul 23, 2025

Geron (GERN.O) Surges 5.08%: What’s Driving the Intraday Rally? - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st

Jul 20, 2025
pulisher
Jul 19, 2025

Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Geron Corporation stock price move sharplyTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jul 15, 2025
pulisher
Jul 13, 2025

Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World

Jul 13, 2025
pulisher
Jul 13, 2025

Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World

Jul 13, 2025
pulisher
Jul 12, 2025

Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN

Jul 12, 2025
pulisher
Jul 10, 2025

Geron resumed with a Sell at Goldman Sachs - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales - Investing.com

Jul 10, 2025
pulisher
Jul 08, 2025

Geron Corp (GERN) Stock: A Year of Highs and Lows - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) - MSN

Jul 07, 2025
pulisher
Jul 06, 2025

13 Stocks Under $5 With High Upside Potential - Insider Monkey

Jul 06, 2025
pulisher
Jul 01, 2025

DSS switches auditors to HTL; no disputes with Grassi reported | GERN SEC FilingForm 4 - Stock Titan

Jul 01, 2025
pulisher
Jun 30, 2025

Geron Corporation(NasdaqGS: GERN) dropped from Russell 2500 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Geron Corporation(NasdaqGS: GERN) dropped from Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Geron Expands Team with 16 New Hires, Awards Over $1.6M in Stock Options and RSUs - Stock Titan

Jun 18, 2025
pulisher
Jun 13, 2025

With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns - Yahoo Finance

Jun 13, 2025
pulisher
Jun 11, 2025

Geron: A Tough First Year For Rytelo, But Not Yet Time To Sell (Downgrade) (NASDAQ:GERN) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 10, 2025

Favourable Signals For Geron: Numerous Insiders Acquired Stock - simplywall.st

Jun 10, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 06, 2025

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Geron Corporation (GERN)May 12, 2025 Deadline to JoinContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 03, 2025

Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN) - Seeking Alpha

Jun 03, 2025
pulisher
Jun 03, 2025

Is Geron Corporation Stock a Bargain Now? - StocksToTrade

Jun 03, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Purchases 14,657 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Geron showcases RYTELO benefits at oncology meetings By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Geron showcases RYTELO benefits at oncology meetings - Investing.com

May 28, 2025
pulisher
May 28, 2025

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles - Investing.com

May 28, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments - Investing.com

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Decreases Stock Holdings in Geron Co. (NASDAQ:GERN) - Defense World

May 27, 2025
pulisher
May 26, 2025

25,148 Shares in Geron Co. (NASDAQ:GERN) Purchased by Lazard Asset Management LLC - Defense World

May 26, 2025
pulisher
May 26, 2025

Geron Co. (NASDAQ:GERN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

May 26, 2025
pulisher
May 22, 2025

Bank of America Corp DE Boosts Stock Position in Geron Co. (NASDAQ:GERN) - Defense World

May 22, 2025
pulisher
May 21, 2025

Investigation announced for Long-Term Investors in shares - openPR.com

May 21, 2025
pulisher
May 20, 2025

Ameriprise Financial Inc. Buys 247,018 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GERN Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Geron Grants $522K Worth of Stock Options and RSUs: New Employee Compensation Details Revealed - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Stifel Financial Corp Increases Position in Geron Co. (NASDAQ:GERN) - Defense World

May 16, 2025

Geron Corp Stock (GERN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Geron Corp Stock (GERN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Samuels Scott Alan
EVP, Chief Legal Officer
Feb 27 '25
Buy
1.61
15,000
24,150
26,682
SCARLETT JOHN A
Chairman, President and CEO
Feb 27 '25
Buy
1.76
12,500
22,062
12,500
Ziegler James
EVP, Chief Commercial Officer
Feb 27 '25
Buy
1.60
100,000
160,000
100,000
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):